Machaiah Madhrira

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Ipilimumab Granulomatous Interstitial Nephritis

Bijin Thajudeen, Machaiah Madhrira, Erika Bracamonte et al. · American Journal of Therapeutics · 2013 · 71 citations

Glomerular Disease, Renal Pathology, Immunology +19

Outcome of Patients on Combined Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy: A Retrospective Study

Bijin Thajudeen, Mahmoud Kamel, Cibi Arumugam et al. · The International Journal of Artificial Organs · 2015 · 35 citations

Acute bilateral renal infarction secondary to cocaine-induced vasospasm

Machaiah Madhrira, Sumit Mohan, Glen S. Markowitz et al. · Kidney International · 2008 · 28 citations · Full text

Thrombosis, Cocaine-induced Vasospasm, Dialysis Therapy +3